NMR detects clustering and ultra-weak excipient interactions governing monoclonal antibody viscosity in formulation-relevant conditions
Liza Boëffard-Dosierre, Camille Dagallier, Géraldine Eudier, Vasco Filipe, Atifa Badar-Majeed, Solène Fraumont, Sophie Zinn-Justin, Francois-Xavier Theillet · 2026
Read NMR detects clustering and ultra-weak excipient interactions governing monoclonal antibody viscosity in formulation-relevant conditions by Liza Boëffard-Dosierre, Camille Dagallier, Géraldine Eudier, Vasco Filipe, Atifa Badar-Majeed, Solène Fraumont, Sophie Zinn-Justin, Francois-Xavier Theillet (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271275.txt.
Description
Liza Boëffard-Dosierre is lead author of a 2026 journal article on why concentrated antibody medicines become thick and hard to inject under the skin. Monoclonal antibodies, lab-made immune proteins, clump together at high strength, and added ingredients called excipients can ease or worsen that clumping through very weak interactions that normal tools miss.
Using nuclear magnetic resonance, a magnet-based measurement method, plus flow and light-scattering tests, the team studied one antibody with several excipients. Arginine and lysine most reduced thickness and self-clumping, while proline and glycine promoted clustering. Lysine bound the antibody best. Some ingredients bound without lowering thickness, showing binding alone does not predict a good formulation.
Catalog record
| CREATOR | Liza Boëffard-Dosierre, Camille Dagallier, Géraldine Eudier, Vasco Filipe, Atifa Badar-Majeed, Solène Fraumont, Sophie Zinn-Justin, Francois-Xavier Theillet |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78367 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |